Globus Medical Inc Class A (GMED)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$85.65
Buy
$89.00
$-2.18 (-2.45%)
Prices updated at 13 Dec 2025, 00:55 EST
| Prices minimum 15 mins delay
Prices in USD
Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 1,568m | 2,519m | |
| 1,020m | 1,484m | |
| 202m | 220m | |
| 12.87 | 8.72 | |
| 123m | 103m | |
| 347m | 474m | |
| Sales, General and administrative | 643m | 981m |
| Interest expenses | - | - |
| Provision for income taxes | 43m | 18m |
| Operating expenses | 818m | 1,264m |
| Income before taxes | 165m | 121m |
| Net income available to common shareholders | 123m | 103m |
| 1.09 | 0.76 | |
| Net interest income | 20m | -4m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 1.07 | 0.75 |
| Free cash flow per share | 1.194 | 2.1592 |
| Book value/share | 30.7131 | 29.6128 |
| Debt equity ratio | 0.127174 | 0.02001 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 1,915m | 2,177m |
| Current liabilities | 392m | 856m |
| Total capital | 4,415m | 4,177m |
| Total debt | 520m | 537m |
| Total equity | 3,998m | 4,177m |
| Total non current liabilities | - | - |
| Loans | 417m | - |
| Total assets | 5,086m | 5,252m |
| Total liabilities | - | - |
| Cash and cash equivalents | 467m | 784m |
| Common stock | 136m | 137m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 150m | 467m |
| Cash dividends paid | - | - |
| 165m | 405m | |
| Investments (gains) losses | 303m | -176m |
| 467m | 784m | |
| Net income | - | - |
| 243m | 521m | |
| -78m | -115m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.